Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome with Predominant Abdominal Bloating: Short- and Long-Term Results from a Placebo-Controlled Randomized Trial

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder associated with intestinal dysbiosis. Given reported promising results of open-label fecal microbiota transplantation (FMT) therapy in patients with predominant abdominal bloating, we studied efficacy of this treatment in a randomized, placebo-controlled trial.

Source: Gastroenterology - July 14, 2020 Category: Gastroenterology Authors: Tom Holvoet, Marie Joossens, Jorge F. V ázquez-Castellanos, Evelien Christiaens, Lander Heyerick, Jerina Boelens, Bruno Verhasselt, Hans van Vlierberghe, Martine De Vos, Jeroen Raes, Danny De Looze Source Type: research